Stephen Robert Sardini

California Institute Of Technology

$198,130

Attributed

$198,130

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $67.6K · FY2020–22

$100K$75K$50K$25K$0

'20

'21

'22

Funding mix

By agency

NIH$198,130 · 1

By mechanism

F32$198,130 · 1

Top collaborators

No co-investigators on record.

Most similar at California Institute Of Technology

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Variant”

Yunda Huang · Fred Hutchinson Cancer Center$63,914,632
Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
Theresa Engel · Leidos Biomedical Research, Inc.$44,839,860
Scott Topper · Broad Institute, Inc.$40,042,399
Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
Evan Z Macosko · Broad Institute, Inc.$29,606,858

Research focus

VariantAffectAnalogBioactive Natural ProductsBiologicalBoronChemical SynthesisChemistryComplexConsequentialismEstersEvaluationFunctional GroupGrantInnovationLeadMethodologyMissionNatural ProductsPharmacologic SubstancePhenolsPositioning AttributePublic HealthQuinones

Grant awards (3)

Efficient and Modular De Novo Synthesis of Hydroxycarvone Derivatives via Pd-Catalyzed Conjugate Addition: Application to theTotal Synthesis of Phorbasone A$67,582

F32 · FY2022 · GM · contact PI

Efficient and Modular De Novo Synthesis of Hydroxycarvone Derivatives via Pd-Catalyzed Conjugate Addition: Application to theTotal Synthesis of Phorbasone A$65,994

F32 · FY2021 · GM · contact PI

Efficient and Modular De Novo Synthesis of Hydroxycarvone Derivatives via Pd-Catalyzed Conjugate Addition: Application to theTotal Synthesis of Phorbasone A$64,554

F32 · FY2020 · GM · contact PI